Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure

Anemia in chronic heart failure: etiology and treatment options

(2009) B Daan Westenbrink et al.   CURRENT OPINION IN CARDIOLOGY

Traditional and Novel Approaches to Management of Heart Failure: Successes and Failures

(2008) Inder S. Anand et al.   CARDIOLOGY CLINICS

Erythropoietin Stimulates Normal Endothelial Progenitor Cell-Mediated Endothelial Turnover, but Attributes to Neovascularization Only in the Presence of Local Ischemia

(2008) B. Daan Westenbrink et al.   CARDIOVASCULAR DRUGS AND THERAPY

Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair

(2008) H. Kobayashi et al.   CARDIOVASCULAR RESEARCH

Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia

(2008) Jalal K. Ghali et al.   CIRCULATION

Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit

(2008) Erik Lipšic et al.   EUROPEAN JOURNAL OF HEART FAILURE

Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?

(2008) Roberto Latini et al.   HEART FAILURE REVIEWS